Atul Sharma, MD
Cardiovascular Disease · New York, NYNPI 1184693228
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Shockwave Medical, Inc at 30.9% of the total. Reporting peaked in 2023 at $12,297 and has fallen 71.6% since, to $3,497 in 2025. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $124.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$8K
- Abbott$4K
- Medtronic$3K
- Spectrawave, Inc$2K
- Philips North America LLC$2K
- Boston Scientific$2K
- plus $5K from 20 others
Across 7 payments — averaging $1559.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$11K
What the payments were for
- Speaking & faculty fees$6,60027%
- Travel & lodging$3,23113%
- Food & beverage$14,52460%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 10 | $7,535 |
| Abbott | 40 | $3,859 |
| Medtronic(2 entities) | 32 | $2,743 |
| Spectrawave, Inc | 15 | $2,096 |
| Philips North America LLC | 17 | $1,765 |
| Boston Scientific | 26 | $1,649 |
| Abiomed | 11 | $1,320 |
| Cardiovascular Systems Inc. | 3 | $873 |
| Johnson & Johnson | 9 | $705 |
| Biotronik Inc. | 4 | $270 |
| Inari Medical, Inc. | 2 | $256 |
| Penumbra, Inc. | 4 | $184 |
| Recor Medical Inc | 1 | $170 |
| Endologix LLC | 1 | $150 |
| Boehringer Ingelheim | 2 | $147 |
| Terumo Medical Corporation | 1 | $147 |
| Atricure, Inc. | 1 | $92 |
| Novartis | 3 | $87 |
| Pfizer | 4 | $81 |
| Amgen | 3 | $67 |
| Kestra Medical Technology Services, Inc. | 1 | $47 |
| E.r. Squibb & Sons, L.L.C. | 1 | $45 |
| Astellas Pharma US Inc | 1 | $21 |
| Chiesi USA, Inc. | 1 | $17 |
| Cordis US CORP. | 1 | $16 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$7,416
- HyperVue Imaging System$1,704
- Starlight Imaging Catheter$1,532
- OPTIS$1,514
- Impella$1,151
- Coronary Orbital Atherectomy System$866
- SYMPLICITY G3$838
- RESOLUTE ONYX$670
- Azurion 7 M20$644
- XARELTO$472
- Xience Sierra Coronary Stent$364
- IGT D Coronary$275
- GENERAL - STENTS$258
- FLOWTRIEVER CATHETER, S$256
- CT THROMBECTOMY SYSTEM KIT$256
- HawkOne$227
- Paradise Ultrasound Renal Denervation System$170
- AVEIR$170
- Perclose ProStyle$156
- AVVIGO Guidance System$153
How this compares
$24,356 in reported general payments places this provider in the 90th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 124 | $167,364 |
| EntrestoSacubitril/Valsartan | 66 | $74,538 |
| XareltoRivaroxaban | 36 | $50,558 |
| BrilintaTicagrelor | 47 | $35,041 |
| JardianceEmpagliflozin | 23 | $30,776 |
| Repatha SureclickEvolocumab | 21 | $28,105 |
| Diclofenac Sodium | 13 | $12,167 |
| Ranolazine ErRanolazine | 67 | $7,432 |
| Metoprolol Succinate | 313 | $4,872 |
| VascepaIcosapent Ethyl | 13 | $3,867 |
| Atorvastatin Calcium | 275 | $3,293 |
| Rosuvastatin Calcium | 160 | $2,226 |
| Ezetimibe | 101 | $2,191 |
| ClopidogrelClopidogrel Bisulfate | 171 | $2,064 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 74 | $1,451 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $81 | $167,364124 claims |
| NovartisEntresto | $87 | $74,53866 claims |
| Johnson & JohnsonXarelto | $705 | $50,55836 claims |
| AstraZenecaBrilinta | $13 | $35,04147 claims |
| Boehringer IngelheimJardiance | $147 | $30,77623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,302 cardiovascular disease providers in New York.
Other cardiovascular disease in New York
- Roger HajjarNew York$5.2M
- Gregg StoneNew York$2M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Megha PrasadNew York$813K
- Eyal HerzogNew York$645K
- Nisha JhalaniNew York$443K
- Roxana MehranNew York$432K
- Howard WeintraubNew York$328K
- Anuradha Lala-TrindadeNew York$324K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.